Published in Medical Device Business Week, January 12th, 2004
"Annette Madrid will tap her considerable experience in directing CNS clinical research as she oversees advanced clinical development of our lead compound in Alzheimer disease," said Rodney Pearlman, PhD, president and chief executive officer of Saegis Pharmaceuticals.
"Her contributions will balance the strength of our management team in target identification and drug discovery, ensuring a smooth transition to the clinic of our growing portfolio of novel therapies for disorders of memory and cognition."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.